ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 128 filers reported holding ADAMAS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $102,000 | -22.7% | 35,263 | +1.2% | 0.00% | – |
| Q4 2019 | $132,000 | -25.8% | 34,856 | 0.0% | 0.00% | – |
| Q3 2019 | $178,000 | -17.6% | 34,856 | 0.0% | 0.00% | – |
| Q2 2019 | $216,000 | -12.9% | 34,856 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $248,000 | -16.8% | 34,856 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $298,000 | -55.7% | 34,856 | +3.7% | 0.00% | 0.0% |
| Q3 2018 | $673,000 | -22.5% | 33,617 | -0.0% | 0.00% | -50.0% |
| Q2 2018 | $868,000 | +38.7% | 33,619 | +28.4% | 0.00% | +100.0% |
| Q1 2018 | $626,000 | -21.6% | 26,179 | +11.2% | 0.00% | -50.0% |
| Q4 2017 | $798,000 | +60.9% | 23,534 | +0.5% | 0.00% | +100.0% |
| Q3 2017 | $496,000 | +9.5% | 23,409 | -9.7% | 0.00% | 0.0% |
| Q2 2017 | $453,000 | -21.4% | 25,914 | -21.3% | 0.00% | 0.0% |
| Q1 2017 | $576,000 | -1.0% | 32,914 | -4.4% | 0.00% | 0.0% |
| Q4 2016 | $582,000 | +0.7% | 34,414 | -2.3% | 0.00% | 0.0% |
| Q3 2016 | $578,000 | +9.1% | 35,214 | +0.6% | 0.00% | 0.0% |
| Q2 2016 | $530,000 | +41.7% | 35,014 | +35.6% | 0.00% | 0.0% |
| Q1 2016 | $374,000 | -31.4% | 25,830 | +34.2% | 0.00% | 0.0% |
| Q4 2015 | $545,000 | +72.5% | 19,252 | +2.0% | 0.00% | 0.0% |
| Q3 2015 | $316,000 | -36.5% | 18,883 | -0.5% | 0.00% | 0.0% |
| Q2 2015 | $498,000 | +429.8% | 18,983 | +254.6% | 0.00% | – |
| Q1 2015 | $94,000 | +1.1% | 5,354 | 0.0% | 0.00% | – |
| Q4 2014 | $93,000 | -6.1% | 5,354 | +0.4% | 0.00% | – |
| Q3 2014 | $99,000 | +2.1% | 5,331 | +0.6% | 0.00% | – |
| Q2 2014 | $97,000 | – | 5,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|